Compare DuPont de Nemours Inc (DD) vs Lufax Holding Ltd (LU) Price & Performance

DuPont (DD) trades at $130.00, down 0.82% on the day, with a neutral technical signal and mixed financial trends. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 contrast with a net loss of $779 million in 2025, though 2026 forecasts show a return to profitability. The company faces headwinds from PFAS litigation settlements and volatile cash flows, but innovation in areas like Tyvek and water technology supports long-term growth prospects.

The outlook for DD is cautiously optimistic, driven by secular growth in healthcare and water technologies, but weighed down by legal liabilities and margin pressures. Analyst consensus is bullish with a 58.54% buy rating, though the $95.00 price target suggests downside risk from current levels. Key risks include ongoing litigation costs and economic sensitivity in construction markets.

Lufax (LU) trades at $0.986, up 0.47% on the day, but shows significant fundamental challenges with consecutive quarterly losses and declining revenue. The company recently completed a 10:1 reverse stock split and faces bearish technical signals despite some oversold RSI readings. Analyst sentiment remains predominantly bullish with 69% buy ratings, pointing to potential value in the depressed valuation multiples.

The investment case hinges on Lufax's deep value proposition trading at 0.07x book value, but requires successful navigation of regulatory headwinds and return to profitability. Key risks include persistent net losses, Chinese regulatory uncertainty, and declining top-line performance that could pressure the stock further despite strong institutional backing from parent company Ping An.